Literature DB >> 15168319

Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin.

Eloisa Gitto1, Russel J Reiter, Stefania P Cordaro, Mariangela La Rosa, Pietro Chiurazzi, Giuseppe Trimarchi, Placido Gitto, Maria P Calabrò, Ignazio Barberi.   

Abstract

Reactive oxygen species play an important role in the pathogenesis of respiratory distress syndrome and its complications. This study was conducted to determine if treatment with the antioxidant melatonin would influence interleukin-6, interleukin-8, tumor necrosis factor alpha, and nitrite/nitrate levels in newborns with grade III or IV respiratory distress syndrome (radiographically confirmed) diagnosed within the first 6 hours of life. Prior to treatment, a blood sample was collected from the umbilical cord or a peripheral vein of each newborn. Second, third, and fourth blood samples were collected at 24 hours, 72 hours, and 7 days, respectively, after beginning treatment with melatonin or placebo. Compared with the melatonin-treated respiratory distress syndrome newborns, in the untreated infants the concentrations of interleukin-6, interleukin-8, and tumor necrosis factor alpha were significantly higher at 24 hours, 72 hours, and at 7 days after onset of the study. in addition, nitrite/nitrate levels at all time points were higher in the untreated respiratory distress syndrome newborns than in the melatonin-treated babies. Following melatonin administration, nitrite/nitrate levels decreased significantly, whereas they remained high and increased further in the respiratory distress syndrome infants not given melatonin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168319     DOI: 10.1055/s-2004-828610

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  40 in total

1.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

2.  Early end-tidal carbon monoxide levels and neurodevelopmental outcome at 3 years 6 months of age in preterm infants.

Authors:  Cornelie A Blok; Tannette G Krediet; Annemiek Kavelaars; Corine Koopman-Esseboom; Hendrik J Vreman; Frank Van Bel
Journal:  Dev Med Child Neurol       Date:  2011-09-20       Impact factor: 5.449

Review 3.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  Timing Matters: Circadian Rhythm in Sepsis, Obstructive Lung Disease, Obstructive Sleep Apnea, and Cancer.

Authors:  Kimberly K Truong; Michael T Lam; Michael A Grandner; Catherine S Sassoon; Atul Malhotra
Journal:  Ann Am Thorac Soc       Date:  2016-07

5.  Pharmacokinetics of melatonin in preterm infants.

Authors:  Nazakat M Merchant; Denis V Azzopardi; Ahmed F Hawwa; James C McElnay; Benita Middleton; J Arendt; Tomoki Arichi; Pierre Gressens; A David Edwards
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

Review 6.  Infant Colic.

Authors:  Amy A Gelfand
Journal:  Semin Pediatr Neurol       Date:  2015-08-17       Impact factor: 1.636

Review 7.  Emerging therapies and management for neonatal encephalopathy-controversies and current approaches.

Authors:  Ryan M McAdams; Megan W Berube
Journal:  J Perinatol       Date:  2021-03-12       Impact factor: 2.521

Review 8.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

9.  Non-surgical periodontal therapy influences salivary melatonin levels.

Authors:  Kristina Bertl; Angelika Schoiber; Hady Haririan; Markus Laky; Irene Steiner; W D Rausch; Oleh Andrukhov; Xiaohui Rausch-Fan
Journal:  Clin Oral Investig       Date:  2012-07-31       Impact factor: 3.573

Review 10.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.